NASDAQ · FACT
FACT II Acquisition Corp
$10.77+$0.01 (+0.09%)
FACT II Acquisition Corp’s quoted price sits in the upper half of its reported 52-week range, 0.09% below the high.
Loading market information…
NASDAQ · ALPA · USD
Stock price, earnings
Quote as of Jul 14, 2023, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Alpha Healthcare Acquisition Corp. III’s quoted price sits in the lower half of its reported 52-week range, 17.16% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Alpha Healthcare Acquisition Corp. III’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Alpha Healthcare Acquisition Corp. III currently lacks significant operational activities. This New York-based firm, established in 2021, is dedicated to executing a business combination—such as a merger, asset acquisition, stock exchange, or reorganization—with one or more entities. Its strategic focus is on identifying, acquiring, and managing a business within the United States' healthcare industry.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:26 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$10.77+$0.01 (+0.09%)
FACT II Acquisition Corp’s quoted price sits in the upper half of its reported 52-week range, 0.09% below the high.
$10.15-$0.01 (-0.1%)
Kadem Sustainable Impact Corporation’s quoted price sits in the upper half of its reported 52-week range, 0.1% below the high.
$10.16+$0.01 (+0.1%)
Northern Genesis Acquisition Corp. III’s quoted price sits in the upper half of its reported 52-week range, 0.39% below the high.
$10.80-$0.01 (-0.05%)
BioPlus Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 7.58% below the high.
$10.36-$0.02 (-0.19%)
ARYA Sciences Acquisition Corp V’s quoted price sits in the upper half of its reported 52-week range, 1.33% below the high.
$10.73-$4.07 (-27.5%)
Galata Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 39.46% below the high.
$11.47+$0.48 (+4.37%)
Tristar Acquisition I Corp.’s quoted price sits in the upper half of its reported 52-week range, 4.5% below the high.
$10.44+$0.01 (+0.1%)
G Squared Ascend II Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.69% below the high.
